Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
about
An overview of the c-MET signaling pathwayMet receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancerTargeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implicationsImmunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis.Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancerBiological approaches to therapy of pancreatic cancer.Pancreatic cancer: molecular pathogenesis and new therapeutic targets.Gene therapy in pancreatic cancer.Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell linesInduction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinomaComparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinomaActivation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.Pancreatic cancer stromal biology and therapy.Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16.Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells.Current knowledge on pancreatic cancer.NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cellsTimosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells.Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cells.PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene.c-MET as a potential therapeutic target and biomarker in cancer.Constitutively active TrkB confers an aggressive transformed phenotype to a neural crest-derived cell line.Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression.A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma.Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis.MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review.Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.
P2860
Q24633986-2BB0F73D-C38B-4CB7-B2E3-D69F960126E7Q27334957-9AB49FCA-2A31-4DC0-BC0C-B5CB49A13C02Q28269990-1B7E4EE9-7F05-4D5E-9A79-6BF8643623CBQ30481528-DF62DFA4-DBBE-41F4-BC07-23F12F0D6A5FQ33868282-C3306F88-F686-4E6E-830F-F6594937E70EQ33899938-3144E6CE-9394-41AA-92A9-7105EA2D9325Q33899954-22DFD797-5F3D-4087-A237-A78CC85DA2CFQ34302954-7EF51183-C24A-440C-B461-6D2C176F8E99Q35102980-43AEB2DA-2807-4353-8163-090593E62F1CQ35208173-022CC1AA-15D3-4865-BE1F-90501B300BF0Q35746620-00DA0A8A-7FC1-47AD-BF02-72754390C21BQ35753107-3DDF01DC-5583-4552-9FD9-94A753F84F09Q35753150-0F65C367-3B24-42E1-B98C-78D0C9E9DA43Q35766799-58A69AA3-83FB-4620-BB27-D5D94AA992A6Q35773996-8169BA13-C8A6-4F81-BF79-9E60FBFDD3D7Q35829375-51B6FC80-70C9-4F81-B787-19A3EDA821D9Q35971808-30FD6FAF-26C8-4F21-8A07-9B641A3E1A95Q36622822-7273CCBE-F3E8-496E-84CA-4A7877D5409AQ37002873-DCAF602E-036E-4EB8-8D88-B60B1C198F64Q37228635-465CC2ED-6262-4BCE-A348-5793A3CF91B7Q37448101-B1570491-C85E-4DE3-AD62-66FF5EABC547Q37962905-E167ED58-AD9E-4BA4-8F7E-EF2FC2564A4BQ39186173-D4580BA6-509F-402F-82F4-D8576210915AQ39961616-E53ABC71-ED1C-4707-9DD7-B66E22A2E4FAQ42017784-DB1665A4-5E15-45D3-8C87-48A65264C5FDQ42700697-1BB99BDB-D715-49EB-B18F-378B20E71303Q43184280-82B416F1-16DC-46D4-83D1-1095EB60F667Q47139946-56174A62-88FC-42C3-9413-653924C858B4Q55284672-782F623A-CAB5-486F-96B8-F9D11B4E75AB
P2860
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
@ast
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
@en
type
label
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
@ast
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
@en
prefLabel
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
@ast
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
@en
P2093
P2860
P1476
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
@en
P2093
P2860
P304
P407
P577
1995-10-01T00:00:00Z